Finance

Lists
FBRX:NASDAQ
Forte Biosciences Inc
$76.94
+0.05%
(+0.035) 1D
Aug 20, 10:44:35 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBRX...
Open
$76.93
High
$76.95
Low
$76.92
Mkt. cap
1.63B
Avg. vol.
2.15M
Volume
2.56M
52-wk high
$77.19
52-wk low
$10.11
EPS
-$4.60
Beta
2.62
Shares outstanding
21.23M
No. of employees
23
Open
$76.93
High
$76.95
Low
$76.92
Mkt. cap
1.63B
Avg. vol.
2.15M
Volume
2.56M
52-wk high
$77.19
52-wk low
$10.11
EPS
-$4.60
Beta
2.62
Shares outstanding
21.23M
No. of employees
23
News stories
From web sources and news partners
About Forte Biosciences Inc
CEO-
Employees23
Founded2007
HeadquartersDallas, Texas, United States
SectorBiotechnology
Websitefortebiorx.com
Analyst ratings
Based on 5 analysts giving stock ratings to FBRX in the past 3 months
Hold
Buy
1
Hold
4
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for FBRX in the last 3 months.
Highest
Current $76.94
$77.00 (+0.08%)
Average
$76.60 (-0.44%)
Lowest
$75.00 (-2.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Etzer Darout
Barclays
Hold
Reiterated
$77.00
+0.1%
08/12/2026
Kumaraguru Raja
Brookline Capital Markets
Hold
Downgraded
$77.00
+0.1%
07/27/2026
Gavin Clark-Gartner
Evercore ISI
Hold
Downgraded
$77.00
+0.1%
07/27/2026
Yaron Werber
TD Cowen
Hold
Downgraded
$77.00
+0.1%
07/27/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$75.00
-2.5%
07/09/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$61.00
-20.7%
05/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.20M
21.74M
20.47M
22.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.18M
2.84M
1.97M
4.77M
Operating expense
18.38M
24.57M
22.44M
27.10M
Total operating expenses
18.38M
24.57M
22.44M
27.10M
Operating income
-18.38M
-24.57M
-22.44M
-27.10M
Other non operating income
701.00K
-1.65M
676.00K
1.46M
EBT including unusual items
-17.68M
-23.75M
-21.76M
-23.14M
EBT excluding unusual items
-17.68M
-23.50M
-21.76M
-25.64M
Income tax expense
-
1.04M
373.00K
193.00K
Effective tax rate
-
-4.37%
-1.71%
-0.83%
Other operating expenses
-
-
-
-
Net income
-17.68M
-24.79M
-22.14M
-23.33M
Net profit margin
-
-
-
-
Earnings per share
-0.99
-1.45
-1.24
-0.97
Interest and investment income
-
2.72M
-
-
Interest expense
-
-
-
-
Net interest expenses
-
2.72M
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.37M
-24.55M
-22.42M
-27.08M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps